Proactiveinvestors United Kingdom Zynerba Pharmaceuticals https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom Zynerba Pharmaceuticals RSS feed en Wed, 20 Nov 2019 09:46:51 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Zynerba Pharmaceuticals wins US patent for treatment of Fragile X syndrome with its Zygel CBD gel https://www.proactiveinvestors.co.uk/companies/news/906863/zynerba-pharmaceuticals-wins-us-patent-for-treatment-of-fragile-x-syndrome-with-its-zygel-cbd-gel-906863.html Tue, 12 Nov 2019 14:29:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/906863/zynerba-pharmaceuticals-wins-us-patent-for-treatment-of-fragile-x-syndrome-with-its-zygel-cbd-gel-906863.html NA Proactive news snapshot: Humanigen, Mirasol Resources, Arcadia Biosciences, Asterion Cannabis, Duos Technologies UPDATE … https://www.proactiveinvestors.co.uk/companies/news/906450/na-proactive-news-snapshot-humanigen-mirasol-resources-arcadia-biosciences-asterion-cannabis-duos-technologies-update--906450.html Wed, 06 Nov 2019 22:10:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/906450/na-proactive-news-snapshot-humanigen-mirasol-resources-arcadia-biosciences-asterion-cannabis-duos-technologies-update--906450.html Zynerba logs dynamic 3Q, to report results from CONNECT-FX study with Zygel CBD gel in 2020 https://www.proactiveinvestors.co.uk/companies/news/906443/zynerba-logs-dynamic-3q-to-report-results-from-connect-fx-study-with-zygel-cbd-gel-in-2020-906443.html Wed, 06 Nov 2019 13:23:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/906443/zynerba-logs-dynamic-3q-to-report-results-from-connect-fx-study-with-zygel-cbd-gel-in-2020-906443.html Zynerba’s CBD gel to treat Fragile X syndrome ventures where Big Pharma fears to tread https://www.proactiveinvestors.co.uk/companies/news/904612/zynerbas-cbd-gel-to-treat-fragile-x-syndrome-ventures-where-big-pharma-fears-to-tread-904612.html Mon, 14 Oct 2019 11:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/904612/zynerbas-cbd-gel-to-treat-fragile-x-syndrome-ventures-where-big-pharma-fears-to-tread-904612.html Zynerba reports positive topline data from BELIEVE 1 study of its CBD gel treatment Zygel in patients with DEE https://www.proactiveinvestors.co.uk/companies/news/902959/zynerba-reports-positive-topline-data-from-believe-1-study-of-its-cbd-gel-treatment-zygel-in-patients-with-dee-902959.html Wed, 18 Sep 2019 12:15:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/902959/zynerba-reports-positive-topline-data-from-believe-1-study-of-its-cbd-gel-treatment-zygel-in-patients-with-dee-902959.html Zynerba shares evidence that CBD may be effective in managing constellation of sociobehavioral symptoms https://www.proactiveinvestors.co.uk/companies/news/902128/zynerba-shares-evidence-that-cbd-may-be-effective-in-managing-constellation-of-sociobehavioral-symptoms-902128.html Thu, 05 Sep 2019 15:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/902128/zynerba-shares-evidence-that-cbd-may-be-effective-in-managing-constellation-of-sociobehavioral-symptoms-902128.html Zynerba boosts cash position in 2Q, gears up for top-line data from key trials with Zygel CBD gel https://www.proactiveinvestors.co.uk/companies/news/900227/zynerba-boosts-cash-position-in-2q-gears-up-for-top-line-data-from-key-trials-with-zygel-cbd-gel-900227.html Tue, 06 Aug 2019 14:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/900227/zynerba-boosts-cash-position-in-2q-gears-up-for-top-line-data-from-key-trials-with-zygel-cbd-gel-900227.html Zynerba Pharmaceuticals joins Russell 3000 and Russell 2000 indexes https://www.proactiveinvestors.co.uk/companies/news/223145/zynerba-pharmaceuticals-joins-russell-3000-and-russell-2000-indexes-223145.html Mon, 01 Jul 2019 12:59:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/223145/zynerba-pharmaceuticals-joins-russell-3000-and-russell-2000-indexes-223145.html Zynerba wins new US patent for treatment of Autism Spectrum Disorder with CBD https://www.proactiveinvestors.co.uk/companies/news/221882/zynerba-wins-new-us-patent-for-treatment-of-autism-spectrum-disorder-with-cbd-221882.html Tue, 11 Jun 2019 11:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/221882/zynerba-wins-new-us-patent-for-treatment-of-autism-spectrum-disorder-with-cbd-221882.html Zynerba tells FDA it should regulate CBD and cannabis-derived products like standard pharmaceuticals https://www.proactiveinvestors.co.uk/companies/news/221313/zynerba-tells-fda-it-should-regulate-cbd-and-cannabis-derived-products-like-standard-pharmaceuticals-221313.html Fri, 31 May 2019 13:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/221313/zynerba-tells-fda-it-should-regulate-cbd-and-cannabis-derived-products-like-standard-pharmaceuticals-221313.html Zynerba launches the Phase 2 trial of its Zygel CBD gel to treat 22q genetic condition https://www.proactiveinvestors.co.uk/companies/news/221134/zynerba-launches-the-phase-2-trial-of-its-zygel-cbd-gel-to-treat-22q-genetic-condition-221134.html Wed, 29 May 2019 16:47:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/221134/zynerba-launches-the-phase-2-trial-of-its-zygel-cbd-gel-to-treat-22q-genetic-condition-221134.html Zynerba boosts cash position in 1Q, gears up for top-line data from four key trials with Zygel CBD gel https://www.proactiveinvestors.co.uk/companies/news/219890/zynerba-boosts-cash-position-in-1q-gears-up-for-top-line-data-from-four-key-trials-with-zygel-cbd-gel-219890.html Wed, 08 May 2019 13:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/219890/zynerba-boosts-cash-position-in-1q-gears-up-for-top-line-data-from-four-key-trials-with-zygel-cbd-gel-219890.html Zynerba Pharmaceuticals scores Fast Track FDA designation for Zygel CBD gel https://www.proactiveinvestors.co.uk/companies/news/219715/zynerba-pharmaceuticals-scores-fast-track-fda-designation-for-zygel-cbd-gel-219715.html Mon, 06 May 2019 16:09:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/219715/zynerba-pharmaceuticals-scores-fast-track-fda-designation-for-zygel-cbd-gel-219715.html Zynerba rockets as investors await CEO's presentation at London conference https://www.proactiveinvestors.co.uk/companies/news/217900/zynerba-rockets-as-investors-await-ceo-s-presentation-at-london-conference-217900.html Wed, 03 Apr 2019 18:15:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/217900/zynerba-rockets-as-investors-await-ceo-s-presentation-at-london-conference-217900.html Zynerba Pharmaceuticals well-funded for its CBD clinical trials into 2021 https://www.proactiveinvestors.co.uk/companies/news/312575/zynerba-pharmaceuticals-well-funded-for-its-cbd-clinical-trials-into-2021-12575.html Tue, 12 Mar 2019 17:24:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/312575/zynerba-pharmaceuticals-well-funded-for-its-cbd-clinical-trials-into-2021-12575.html Zynerba’s 4Q shows momentum as it heads into key clinical trial https://www.proactiveinvestors.co.uk/companies/news/216216/zynerbas-4q-shows-momentum-as-it-heads-into-key-clinical-trial-216216.html Mon, 11 Mar 2019 17:39:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/216216/zynerbas-4q-shows-momentum-as-it-heads-into-key-clinical-trial-216216.html Zynerba Pharmaceuticals launches Phase 2 trial of Zygel in autism spectrum disorder https://www.proactiveinvestors.co.uk/companies/news/216010/zynerba-pharmaceuticals-launches-phase-2-trial-of-zygel-in-autism-spectrum-disorder-216010.html Thu, 07 Mar 2019 12:56:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/216010/zynerba-pharmaceuticals-launches-phase-2-trial-of-zygel-in-autism-spectrum-disorder-216010.html Zynerba Pharmaceuticals receives new US patent for treatment of Fragile X syndrome with CBD https://www.proactiveinvestors.co.uk/companies/news/215326/zynerba-pharmaceuticals-receives-new-us-patent-for-treatment-of-fragile-x-syndrome-with-cbd-215326.html Tue, 26 Feb 2019 13:42:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/215326/zynerba-pharmaceuticals-receives-new-us-patent-for-treatment-of-fragile-x-syndrome-with-cbd-215326.html Zynerba Pharmaceuticals’ quest for CBD gel to treat Fragile X syndrome ventures where big pharma fears to tread https://www.proactiveinvestors.co.uk/companies/news/215151/zynerba-pharmaceuticals-quest-for-cbd-gel-to-treat-fragile-x-syndrome-ventures-where-big-pharma-fears-to-tread-215151.html Fri, 22 Feb 2019 15:19:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/215151/zynerba-pharmaceuticals-quest-for-cbd-gel-to-treat-fragile-x-syndrome-ventures-where-big-pharma-fears-to-tread-215151.html Zynerba Pharmaceuticals adds pharma exec to its board https://www.proactiveinvestors.co.uk/companies/news/214974/zynerba-pharmaceuticals-adds-pharma-exec-to-its-board-214974.html Wed, 20 Feb 2019 14:14:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/214974/zynerba-pharmaceuticals-adds-pharma-exec-to-its-board-214974.html Zynerba updates on its two clinical CBD studies https://www.proactiveinvestors.co.uk/companies/news/312172/zynerba-updates-on-its-two-clinical-cbd-studies-12172.html Mon, 11 Feb 2019 22:05:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/312172/zynerba-updates-on-its-two-clinical-cbd-studies-12172.html Proactive Investors cannabis conference in New York showcases industry potential for investors https://www.proactiveinvestors.co.uk/companies/news/213750/proactive-investors-cannabis-conference-in-new-york-showcases-industry-potential-for-investors-213750.html Thu, 31 Jan 2019 16:03:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/213750/proactive-investors-cannabis-conference-in-new-york-showcases-industry-potential-for-investors-213750.html Zynerba Pharmaceuticals stock soars amid slew of positive drivers https://www.proactiveinvestors.co.uk/companies/news/213552/zynerba-pharmaceuticals-stock-soars-amid-slew-of-positive-drivers-213552.html Wed, 30 Jan 2019 14:15:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/213552/zynerba-pharmaceuticals-stock-soars-amid-slew-of-positive-drivers-213552.html SCYNEXIS names Zynerba CEO Armando Anido to its board https://www.proactiveinvestors.co.uk/companies/news/213086/scynexis-names-zynerba-ceo-armando-anido-to-its-board-213086.html Tue, 22 Jan 2019 15:05:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/213086/scynexis-names-zynerba-ceo-armando-anido-to-its-board-213086.html Zynerba on track to report cannabidiol gel treatment results for Fragile X childhood disorder https://www.proactiveinvestors.co.uk/companies/news/211523/zynerba-on-track-to-report-cannabidiol-gel-treatment-results-for-fragile-x-childhood-disorder-211523.html Wed, 19 Dec 2018 19:25:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/211523/zynerba-on-track-to-report-cannabidiol-gel-treatment-results-for-fragile-x-childhood-disorder-211523.html Zynerba Pharmaceuticals CEO welcomes FDA approval of cannabinoid products https://www.proactiveinvestors.co.uk/companies/news/208544/zynerba-pharmaceuticals-ceo-welcomes-fda-approval-of-cannabinoid-products-208544.html Mon, 05 Nov 2018 17:54:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/208544/zynerba-pharmaceuticals-ceo-welcomes-fda-approval-of-cannabinoid-products-208544.html Zynerba Pharmaceuticals anticipates data in late 2019 for its phase 3 cannabinoid drug https://www.proactiveinvestors.co.uk/companies/news/310912/zynerba-pharmaceuticals-anticipates-data-in-late-2019-for-its-phase-3-cannabinoid-drug-10912.html Thu, 18 Oct 2018 15:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/310912/zynerba-pharmaceuticals-anticipates-data-in-late-2019-for-its-phase-3-cannabinoid-drug-10912.html Daily CryptoCann Report: Buy a classic car with crypto; WeedMD inks distribution deal in Alberta https://www.proactiveinvestors.co.uk/companies/news/200237/daily-cryptocann-report-buy-a-classic-car-with-crypto-weedmd-inks-distribution-deal-in-alberta-200237.html Thu, 05 Jul 2018 16:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/200237/daily-cryptocann-report-buy-a-classic-car-with-crypto-weedmd-inks-distribution-deal-in-alberta-200237.html Zynerba Pharmaceuticals shares sink after unsuccessful trial of cannabis-based skin patch https://www.proactiveinvestors.co.uk/companies/news/200216/zynerba-pharmaceuticals-shares-sink-after-unsuccessful-trial-of-cannabis-based-skin-patch-200216.html Thu, 05 Jul 2018 12:57:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/200216/zynerba-pharmaceuticals-shares-sink-after-unsuccessful-trial-of-cannabis-based-skin-patch-200216.html Zynerba Pharmaceuticals shares plunge after its net loss in 1Q widens https://www.proactiveinvestors.co.uk/companies/news/196588/zynerba-pharmaceuticals-shares-plunge-after-its-net-loss-in-1q-widens-196588.html Tue, 08 May 2018 19:36:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/196588/zynerba-pharmaceuticals-shares-plunge-after-its-net-loss-in-1q-widens-196588.html Zynerba Pharmaceuticals shares tank after disappointing epilepsy trial results https://www.proactiveinvestors.co.uk/companies/news/182065/zynerba-pharmaceuticals-shares-tank-after-disappointing-epilepsy-trial-results-182065.html Mon, 07 Aug 2017 13:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/182065/zynerba-pharmaceuticals-shares-tank-after-disappointing-epilepsy-trial-results-182065.html Zynerba Pharma to highlight data to American Epilepsy Society https://www.proactiveinvestors.co.uk/companies/news/169614/zynerba-pharma-to-highlight-data-to-american-epilepsy-society-169614.html Mon, 28 Nov 2016 14:03:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/169614/zynerba-pharma-to-highlight-data-to-american-epilepsy-society-169614.html Zynerba doses first patient in epilepsy gel trial https://www.proactiveinvestors.co.uk/companies/news/128853/zynerba-doses-first-patient-in-epilepsy-gel-trial-128853.html Mon, 01 Aug 2016 13:27:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/128853/zynerba-doses-first-patient-in-epilepsy-gel-trial-128853.html